Restructuring continues to deliver earnings growth to aquaculture health group Benchmark

All of Benchmark's business segments -- advanced nutrition, genetics and animal health -- showed improvements during the company's third fiscal quarter.

The result represents a continuation of the operational and financial progress following the 2020 restructuring, CEO Trond Williksen said.
The result represents a continuation of the operational and financial progress following the 2020 restructuring, CEO Trond Williksen said.Photo: YouTube/EnovaNO
Published 25 August 2022, 09:18Updated 25 August 2022, 09:18
BenchmarkNorwayEuronext GrowthOslo Stock ExchangeGenetics